AI assistant
Sending…
Chemours Co — Director's Dealing 2022
Apr 1, 2022
31561_dirs_2022-04-01_c8b5491e-25f8-44c8-b4d5-67421b03d9f6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2022-03-31
Reporting Person: Kane Erin N (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | Stock Units | $ | A | 794.155 | Acquired | Common Stock (794.155) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 27343.5076 | Direct |
Footnotes
F1: Includes stock units and dividend equivalent units.
F2: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.
F3: Payable upon separation from service.
More from Chemours Co
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3